Policy/Regulation Fact Sheet

INTRODUCTION

The 21

st

Century Cures Act was approved

and passed by both houses of Congress in

2016. It was later signed into law by

President Barack Obama in December of

2016.

The law covers many healthcare

aspects one of which is related to health

informatics.

The goals for

the formulation of the

formulation of the policy was to help in

modernizing and personalization of

healthcare, encouraging for greater

innovation, supporting of research, and

streamlining of the healthcare system

(Avorn & Kesselheim, 2015)

.

It was aimed a

t streamlining the discovery

of medicine through basic science and

unleashing the power of digital medicine

and social media at the treatment delivery

phase

(Majumder, Guerrini, Bollinger,

Cook

-

Deegan & McGuire, 2017)

.

IMPACT OF THE POLICY ON SYSTEM

IMPLEMENTATION

The policy enabled for the definition of

interoperability and prohibition of

information blocking. Information

blocking can be describe

d

as the practice

that prevents the access to electronic health

informatio

n

or any data that related to the

medical treatment of a patient.

IMPACT ON CLINICAL CARE AND

WORKFLOW

The following are the impact on the law on

clinical care and workflow:

·

Reduction of fraud in health care

leading to increased satisfaction of

patients

·

Increment in advances in access to

health information

·

Increment of access to care that is

enabled by health information

technology

·

Reduction in discriminatory efforts

which frust

r

ate

efforts which

enable interoperability.

ORGANI

ZATIONAL POLICIES

The following are organizational policies

which will be implemented to address the

regulation

:

·

Improvement of health information

systems to

allow for

interoperability.

·

Organization commitment to

fulfilling the regulation.

·

Punitive meas

ures for violators

within the company.

REFERENCES

·

Avorn, J., & Kesselheim, A. S.

(2015). The 21st Century Cures

Act

—

will it take us back in

time?.

New England Journal of

Medicine

,

372(26), 2473

-

2475.

·

Majumder, M. A., Guerrini, C. J.,

Bollinger, J. M.,

Cook

-

Deegan, R.,

& McGuire, A. L. (2017). Sharing

data under the 21st Century Cures

Act.

Genetics in Medicine

,

19(12),

1289

-

1294

.

INTRODUCTION

The 21

st

Century Cures Act was approved

and passed by both houses of Congress in

2016. It was later signed into law by

President Barack Obama in December of

2016. The law covers many healthcare

aspects one of which is related to health

informatics.

The goals for the formulation of the

formulation of the policy was to help in

modernizing and personalization of

healthcare, encouraging for greater

innovation, supporting of research, and

streamlining of the healthcare system

(Avorn & Kesselheim, 2015).

It was aimed at streamlining the discovery

of medicine through basic science and

unleashing the power of digital medicine

and social media at the treatment delivery

phase (Majumder, Guerrini, Bollinger,

Cook-Deegan & McGuire, 2017).

IMPACT OF THE POLICY ON SYSTEM

IMPLEMENTATION

The policy enabled for the definition of

interoperability and prohibition of

information blocking. Information

blocking can be described as the practice

that prevents the access to electronic health

information or any data that related to the

medical treatment of a patient.

IMPACT ON CLINICAL CARE AND

WORKFLOW

The following are the impact on the law on

clinical care and workflow:

 Reduction of fraud in health care

leading to increased satisfaction of

patients

 Increment in advances in access to

health information

 Increment of access to care that is

enabled by health information

technology

 Reduction in discriminatory efforts

which frustrate efforts which

enable interoperability.

ORGANIZATIONAL POLICIES

The following are organizational policies

which will be implemented to address the

regulation:

 Improvement of health information

systems to allow for

interoperability.

 Organization commitment to

fulfilling the regulation.

 Punitive measures for violators

within the company.

REFERENCES

 Avorn, J., & Kesselheim, A. S.

(2015). The 21st Century Cures

Act—will it take us back in

time?. New England Journal of

Medicine, 372(26), 2473-2475.

 Majumder, M. A., Guerrini, C. J.,

Bollinger, J. M., Cook-Deegan, R.,

& McGuire, A. L. (2017). Sharing

data under the 21st Century Cures

Act. Genetics in Medicine, 19(12),

1289-1294.